◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › NUWE

Nuwellis, Inc. (NUWE) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-09

Nuwellis, Inc. (NUWE) operates in the Medical Devices industry and is headquartered in Eden Prairie, United States with about 38 employees. Its market capitalization is roughly $0 million. In the fiscal year ended 2025-12-31, NUWE reported $8M in revenue and ($18M) in net income.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

Interactive charts & full statements → Open the NUWE valuation workbench →

NUWE Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$8M$9M$9M$8M
Gross Profit$5M$6M$5M$5M
Operating Income (EBIT)($11M)($11M)($18M)($17M)
Net Income($18M)($11M)($20M)($14M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NUWE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$2M$2M$2M$2M$2M
Gross Profit$2M$2M$1M$1M$1M
Operating Income (EBIT)($5M)($2M)($3M)($3M)($3M)
Net Income($4M)($2M)$0M($13M)($3M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NUWE Free Cash Flow History

NUWE Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$6M$10M$10M$25M
Total Liabilities$4M$3M$7M$12M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NUWE viewer.

Other Companies in Medical Devices

← NUWAll stocksNVAX →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.